학술논문
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study
Document Type
Journal
Author
Amin, Janaki; Becker, Stephen; Belloso, Waldo; To, Marta Boffi; Cooper, David; Crabtree-Ramirez, Brenda; Duncombe, Chris; Emery, Sean; Foulkes, Sharne; Hill, Andrew; Jessen, Heiko; Kumar, Suresh; Lee, Man-Po; Losso, Marcelo; Nwizu, Chidi; Phanuphak, Praphan; Rooney, Tim Read Jim; Er, Kim Schaff; Shahar, Eduardo; Winston, Alan; Wolff, Marcelo; Young, Barnaby; Abela, Cecilia; Avihingsanon, Anchalee; Boyd, Mark; Carey, Dianne; Clarke, Amanda; Courtney-Vega, Kymme; No, Marina Delfi; Donaldson, Anna; Espinosa, Natalie; Johannesen, Tanya; Lin, Enmoore; Moricz, Alejandra; Pett, Sarah; Phanupak, Praphan; Puls, Rebekah; Pussadee, Kanitta; Sutheerasak, Parinya; Tomlins, Louise; Ubolyam, Sasiwimol; Azwa, Raja Iskandar Shah bin Raja; Bissio, Emiliano; Calanni, Liliana; Chetchotisakd, Ploenchan; Doong, Nicholas; Elliott, Julian; Gazzard, Brian; Kelly, Mark; Laplume, Hector; Luna, Norma del Carmen; Lupo, Sergio; Messina, Oscar Garcia; Mohapi, Lerato; Moore, Richard; Nolan, David; Orrell, Catherine; Perez, Carlos; Read, Tim; Rockstroh, Juergen; Rowling, Diane; Supparatpinyo, Khuanchai; Smith, Don; Villanueva, Jaime Andrade; Vlahakis, Emanuel; Kelleher, Tony; Cunningham, Philip; Merlin, Kate; Yeung, Julie; Shaik, Ansari; Fsadni, Bertha; Carrera, Alex; Lograsso, Melanie; Gulick, Roy; Dunn, David; Dolan, Matthew; ENCORE1 Study Grp
Source
Subject
Language
English
ISSN
14744457